We are live on
!
Find out more
AG
Algert Global Portfolio holdings
AUM
$6.65B
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+12.84%
1 Year Est. Return
+53.68%
3 Year Est. Return
+140.8%
5 Year Est. Return
+204.57%
10 Year Est. Return
+1,528.09%
AUM
$482M
AUM Growth
-$34.5M
(-6.7%)
Cap. Flow
-$70M
Cap. Flow
% of AUM
-14.53%
Top 10 Holdings %
Top 10 Hldgs %
9.74%
Holding
418
New
94
Increased
82
Reduced
150
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$3.77M |
| 2 |
Atkore
ATKR
|
+$3.72M |
| 3 |
H&R Block
HRB
|
+$3.62M |
| 4 |
Terex
TEX
|
+$3.58M |
| 5 |
Malibu Boats
MBUU
|
+$3.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek US
DK
|
+$5.65M |
| 2 |
Supernus Pharmaceuticals
SUPN
|
+$5.34M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.77M |
| 4 |
Valero Energy
VLO
|
+$4.12M |
| 5 |
HDNG
Hardinge Inc
HDNG
|
+$4.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 24.53% |
| 2 | Technology | 18.56% |
| 3 | Consumer Discretionary | 16.15% |
| 4 | Healthcare | 13.22% |
| 5 | Materials | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
LifeVantage
LFVN
$79.9M
| $466K | 0.1% |
73,169
-337
| -0.5% | -$1.53K |
|
|
UCB
252
United Community Banks
UCB
$4.2B
| $456K | 0.09% |
14,870
+220
| +2% | +$7.16K |
|
|
ADVM
253
DELISTED
Adverum Biotechnologies
ADVM
| $436K | 0.09% |
8,231
+933
| +13% | +$56.1K |
|
|
RDUS
254
DELISTED
Radius Recycling
RDUS
| $436K | 0.09% |
12,940
-1,112
| -8% | -$35.5K |
|
|
CSFL
255
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $432K | 0.09% |
+14,490
| New | +$431K |
|
256
Universal Corp
UVV
$1.33B
| $431K | 0.09% |
+6,524
| New | +$361K |
|
|
SRRA
257
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $426K | 0.09% |
3,600
+3,012
| +512% | +$302K |
|
258
ITT
ITT
$17.1B
| $418K | 0.09% |
7,989
-600
| -7% | -$31.3K |
|
259
Global Industrial
GIC
$1.32B
| $413K | 0.09% |
+12,030
| New | +$384K |
|
|
KEM
260
DELISTED
KEMET Corporation
KEM
| $406K | 0.08% |
16,807
+2,546
| +18% | +$51.8K |
|
261
SPS Commerce
SPSC
$2.27B
| $403K | 0.08% |
10,960
-5,698
| -34% | -$202K |
|
|
IOTS
262
DELISTED
Adesto Technologies Corp
IOTS
| $403K | 0.08% |
47,947
-35,220
| -42% | -$308K |
|
263
Alto Ingredients
ALTO
$384M
| $394K | 0.08% |
151,421
-36,815
| -20% | -$117K |
|
|
264
Delek US
DK
$4.2B
| $383K | 0.08% |
7,630
-113,554
| -94% | -$5.65M |
|
265
Transcat
TRNS
$816M
| $375K | 0.08% |
+19,852
| New | +$352K |
|
|
ARTX
266
DELISTED
Arotech Corporation
ARTX
| $373K | 0.08% |
99,553
+88,503
| +801% | +$315K |
|
267
Travere Therapeutics
TVTX
$5.2B
| $358K | 0.07% |
+13,130
| New | +$350K |
|
|
HIBB
268
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $356K | 0.07% |
+15,563
| New | +$406K |
|
269
Capri Holdings
CPRI
$1.85B
| $355K | 0.07% |
5,335
-450
| -8% | -$29.4K |
|
270
Cal-Maine
CALM
$3.97B
| $354K | 0.07% |
+7,721
| New | +$373K |
|
271
Stepan Co
SCL
$1.33B
| $351K | 0.07% |
+4,495
| New | +$343K |
|
272
Vericel Corp
VCEL
$2.36B
| $350K | 0.07% |
36,067
-5,033
| -12% | -$62.7K |
|
273
Protagonist Therapeutics
PTGX
$8.86B
| $349K | 0.07% |
+51,907
| New | +$398K |
|
|
ARQL
274
DELISTED
Arqule Inc
ARQL
| $349K | 0.07% |
+63,190
| New | +$241K |
|
|
ARC
275
DELISTED
ARC Document Solutions, Inc.
ARC
| $346K | 0.07% |
195,725
-20,570
| -10% | -$42.9K |
|
Similar funds
TB
CI
MIP
AS
NMIMC
AACR
MSE
FLPIM
Algert Global's Q2 2018 Portfolio in Review
As of Q2 2018, Algert Global held 418 positions worth $482M, down 6.7% from $516M the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Algert Global withdrew a net $70M in Q2 2018, closing 90 positions and reducing 150 holdings. Its most notable exit was Hardinge Inc, an estimated $4.08M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 25% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Algert Global opened a new position in LyondellBasell Industries worth $3.77M.
- Algert Global's largest Q2 2018 buy was LyondellBasell Industries: 34,319 shares worth $3.77M.
- Algert Global added most to Idexx Laboratories in Q2 2018, an estimated $2.73M increase.
- Algert Global's biggest Q2 2018 reduction was Delek US, cutting an estimated $5.65M.
- Algert Global fully exited Hardinge Inc in Q2 2018, selling an estimated $4.08M.
- Algert Global's ten largest holdings make up 9.7% of its $482M portfolio in Q2 2018.
- Algert Global opened 94 new positions and closed 90 in Q2 2018.
- Algert Global's portfolio value fell 6.7% quarter-over-quarter to $482M.
Based on Algert Global's 13F filing for Q2 2018, filed 2 Aug 2018.